ClinicalTrials.Veeva

Menu

Shanghai Meiji Health Science and Technology Co., Ltd

M

Meiji Seika Pharma

Status

Completed

Conditions

Over Weight People

Treatments

Dietary Supplement: Nelumbo nucifera Leaf Extract

Study type

Interventional

Funder types

Industry

Identifiers

NCT04651023
ShanghaiMHST

Details and patient eligibility

About

Investigators performed a randomized double-blind trial to determine the effects of long-term NnEx ingestion in patients with overweight or obesity. Ninety-five participants (23<BMI<30 kg/m2) were randomly allocated to three groups: a control group, a 1 g/day NnEx group, and a 2 g/day NnEx group. The effects of the consumption of 2 g/day or 1 g/day NnEx for 12 weeks on indices of adiposity and fasting blood metabolic parameters were compared with those of no consumption of NnEx.

Enrollment

95 patients

Sex

All

Ages

40 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Has a body mass index (BMI) of 23-30 kg/m2
  • Has no history of using any antidiabetic medication
  • Absence of liver, kidney, or heart disease
  • Absence of food allergy and daily tea consumption <2 L
  • Meet all of the above criteria and to follow the instructions given during the study.

Exclusion criteria

  • Testing delayed for >1 week without justification
  • Difficulty attending the hospital on the required days
  • Lack of data regarding the times of beverage consumption for over 5% of the study
  • Abnormal overeating
  • Test results believed to be unreliable because of the lack of provision of diet and exercise reports during the fasting period
  • Difficulty drawing blood
  • Poor confidence in the test data

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

95 participants in 3 patient groups, including a placebo group

control group
Placebo Comparator group
Description:
During the 12-week study period, the participants consumed two bottles (2 \*200 mL) of the experimental beverage (0g NnEx) per day with or after meals.
Treatment:
Dietary Supplement: Nelumbo nucifera Leaf Extract
low concentration of NnEx group
Experimental group
Description:
During the 12-week study period, the participants consumed two bottles (2 \*200 mL) of the experimental beverage (1g NnEx) per day with or after meals.
Treatment:
Dietary Supplement: Nelumbo nucifera Leaf Extract
high concentration of NnEx group
Experimental group
Description:
During the 12-week study period, the participants consumed two bottles (2 \*200 mL) of the experimental beverage (2g NnEx) per day with or after meals.
Treatment:
Dietary Supplement: Nelumbo nucifera Leaf Extract

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems